James Mock

Track

Insider profile

Currently holds a position at Revvity, Inc.

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Senior Vice President Revvity, Inc. May 1, 2018 -
James Mock's trades of Moderna Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Moderna Inc (MRNA)
Transaction date
Planned sale
Price
445.57
Quantity 83,555 -26.6%
Value US$4,327,255
US Moderna Inc (MRNA)
Transaction date
Planned sale
Price
275.07
Quantity 47,767 -49.7%
Value US$1,607,636
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
395.66
Quantity 71,887
Value US$4,611,817
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
134.49
Quantity 34,836
Value US$4,685,094
US Moderna Inc (MRNA)
Transaction date
Sale
Price
42.79
Quantity 1,420 -11.4%
Value US$60,761
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
42.79
Quantity 1,420
Value US$60,761
US Moderna Inc (MRNA)
Transaction date
Sale
Price
60.12
Quantity 715 -7.0%
Value US$42,986
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
60.12
Quantity 715
Value US$42,986
US Moderna Inc (MRNA)
Transaction date
Sale
Price
78.03
Quantity 162 -1.8%
Value US$12,640
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
78.03
Quantity 162
Value US$12,640
US Moderna Inc (MRNA)
Transaction date
Sale
Price
79.39
Quantity 1,321 -13.3%
Value US$104,881
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
79.39
Quantity 1,321
Value US$104,881
US Moderna Inc (MRNA)
Transaction date
Sale
Price
118.24
Quantity 689 -8.7%
Value US$81,465
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
118.24
Quantity 689
Value US$81,465
US Moderna Inc (MRNA)
Transaction date
Sale
Price
140.72
Quantity 691 -9.6%
Value US$97,237
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
140.72
Quantity 691
Value US$97,237
US Moderna Inc (MRNA)
Transaction date
Sale
Price
144.50
Quantity 183 -3.0%
Value US$26,444
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
144.50
Quantity 183
Value US$26,444
US Moderna Inc (MRNA)
Transaction date
Sale
Price
162.47
Quantity 648 -10.2%
Value US$105,283
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
162.47
Quantity 648
Value US$105,283
US Moderna Inc (MRNA)
Transaction date
Sale
Price
101.93
Quantity 705 -12.3%
Value US$71,859
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
101.93
Quantity 705
Value US$71,859
US Moderna Inc (MRNA)
Transaction date
Sale
Price
94.57
Quantity 647 -13.1%
Value US$61,188
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
94.57
Quantity 647
Value US$61,188
US Moderna Inc (MRNA)
Transaction date
Sale
Price
109.75
Quantity 772 -17.5%
Value US$84,731
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
109.75
Quantity 772
Value US$84,731
US Moderna Inc (MRNA)
Transaction date
Sale
Price
102.50
Quantity 2,858 -49.2%
Value US$292,953
US Moderna Inc (MRNA)
Transaction date
Proposed sale
Price
102.50
Quantity 2,858
Value US$292,953
US Revvity, Inc. (RVTY)
Transaction date
Planned sale
Price
146.34
Quantity 663 -2.3%
Value US$97,023
US Revvity, Inc. (RVTY)
Transaction date
Planned sale
Price
145.78
Quantity 2,290 -7.5%
Value US$333,836
US Revvity, Inc. (RVTY)
Transaction date
Planned sale
Price
144.90
Quantity 2,072 -6.4%
Value US$300,233
US Revvity, Inc. (RVTY)
Transaction date
Planned sale
Price
125.08
Quantity 100 -0.4%
Value US$12,508
US Revvity, Inc. (RVTY)
Transaction date
Planned sale
Price
124.58
Quantity 4,423 -13.9%
Value US$551,017
US Revvity, Inc. (RVTY)
Transaction date
Planned sale
Price
123.69
Quantity 1,100 -3.3%
Value US$136,059
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-10
US Moderna Inc (MRNA)
PlS Planned sale
83,555 -26.6%
445.57
US$4,327,255 		83,555 -26.6% 445.57 US$4,327,255
2026-09-14 2026-09-10
US Moderna Inc (MRNA)
PlS Planned sale
47,767 -49.7%
275.07
US$1,607,636 		47,767 -49.7% 275.07 US$1,607,636
2026-09-10 2026-09-10
US Moderna Inc (MRNA)
PrS Proposed sale
71,887
395.66
US$4,611,817 		71,887 395.66 US$4,611,817
2026-09-10 2026-09-10
US Moderna Inc (MRNA)
PrS Proposed sale
34,836
134.49
US$4,685,094 		34,836 134.49 US$4,685,094
2024-12-02 2024-11-29
US Moderna Inc (MRNA)
S Sale
1,420 -11.4%
42.79
US$60,761 		1,420 -11.4% 42.79 US$60,761
2024-11-29 2024-11-29
US Moderna Inc (MRNA)
PrS Proposed sale
1,420
42.79
US$60,761 		1,420 42.79 US$60,761
2024-10-08 2024-10-07
US Moderna Inc (MRNA)
S Sale
715 -7.0%
60.12
US$42,986 		715 -7.0% 60.12 US$42,986
2024-10-07 2024-10-07
US Moderna Inc (MRNA)
PrS Proposed sale
715
60.12
US$42,986 		715 60.12 US$42,986
2024-08-30 2024-08-29
US Moderna Inc (MRNA)
S Sale
162 -1.8%
78.03
US$12,640 		162 -1.8% 78.03 US$12,640
2024-08-29 2024-08-29
US Moderna Inc (MRNA)
PrS Proposed sale
162
78.03
US$12,640 		162 78.03 US$12,640
2024-08-29 2024-08-28
US Moderna Inc (MRNA)
S Sale
1,321 -13.3%
79.39
US$104,881 		1,321 -13.3% 79.39 US$104,881
2024-08-28 2024-08-28
US Moderna Inc (MRNA)
PrS Proposed sale
1,321
79.39
US$104,881 		1,321 79.39 US$104,881
2024-07-09 2024-07-08
US Moderna Inc (MRNA)
S Sale
689 -8.7%
118.24
US$81,465 		689 -8.7% 118.24 US$81,465
2024-07-08 2024-07-08
US Moderna Inc (MRNA)
PrS Proposed sale
689
118.24
US$81,465 		689 118.24 US$81,465
2024-06-04 2024-06-03
US Moderna Inc (MRNA)
S Sale
691 -9.6%
140.72
US$97,237 		691 -9.6% 140.72 US$97,237
2024-06-03 2024-06-03
US Moderna Inc (MRNA)
PrS Proposed sale
691
140.72
US$97,237 		691 140.72 US$97,237
2024-05-30 2024-05-29
US Moderna Inc (MRNA)
S Sale
183 -3.0%
144.50
US$26,444 		183 -3.0% 144.50 US$26,444
2024-05-29 2024-05-29
US Moderna Inc (MRNA)
PrS Proposed sale
183
144.50
US$26,444 		183 144.50 US$26,444
2024-05-29 2024-05-28
US Moderna Inc (MRNA)
S Sale
648 -10.2%
162.47
US$105,283 		648 -10.2% 162.47 US$105,283
2024-05-28 2024-05-28
US Moderna Inc (MRNA)
PrS Proposed sale
648
162.47
US$105,283 		648 162.47 US$105,283
2024-04-09 2024-04-08
US Moderna Inc (MRNA)
S Sale
705 -12.3%
101.93
US$71,859 		705 -12.3% 101.93 US$71,859
2024-04-08 2024-04-08
US Moderna Inc (MRNA)
PrS Proposed sale
705
101.93
US$71,859 		705 101.93 US$71,859
2024-03-01 2024-02-29
US Moderna Inc (MRNA)
S Sale
647 -13.1%
94.57
US$61,188 		647 -13.1% 94.57 US$61,188
2024-02-29 2024-02-29
US Moderna Inc (MRNA)
PrS Proposed sale
647
94.57
US$61,188 		647 94.57 US$61,188
2024-01-09 2024-01-08
US Moderna Inc (MRNA)
S Sale
772 -17.5%
109.75
US$84,731 		772 -17.5% 109.75 US$84,731
2024-01-08 2024-01-08
US Moderna Inc (MRNA)
PrS Proposed sale
772
109.75
US$84,731 		772 109.75 US$84,731
2023-10-10 2023-10-06
US Moderna Inc (MRNA)
S Sale
2,858 -49.2%
102.50
US$292,953 		2,858 -49.2% 102.50 US$292,953
2023-10-06 2023-10-06
US Moderna Inc (MRNA)
PrS Proposed sale
2,858
102.50
US$292,953 		2,858 102.50 US$292,953
2022-06-27 2022-06-24
US Revvity, Inc. (RVTY)
PlS Planned sale
663 -2.3%
146.34
US$97,023 		663 -2.3% 146.34 US$97,023
2022-06-27 2022-06-24
US Revvity, Inc. (RVTY)
PlS Planned sale
2,290 -7.5%
145.78
US$333,836 		2,290 -7.5% 145.78 US$333,836
2022-06-27 2022-06-24
US Revvity, Inc. (RVTY)
PlS Planned sale
2,072 -6.4%
144.90
US$300,233 		2,072 -6.4% 144.90 US$300,233
2020-10-05 2020-10-02
US Revvity, Inc. (RVTY)
PlS Planned sale
100 -0.4%
125.08
US$12,508 		100 -0.4% 125.08 US$12,508
2020-10-05 2020-10-02
US Revvity, Inc. (RVTY)
PlS Planned sale
4,423 -13.9%
124.58
US$551,017 		4,423 -13.9% 124.58 US$551,017
2020-10-05 2020-10-02
US Revvity, Inc. (RVTY)
PlS Planned sale
1,100 -3.3%
123.69
US$136,059 		1,100 -3.3% 123.69 US$136,059